BGI Genomics and Roche Diagnostics have rolled out tests for Alzheimer's disease in China, the companies said, in an effort ...

There are indications that a simple finger-prick blood test could, in the future, detect Alzheimer's disease long before the ...

Researchers analyzed the diagnostic value of stereotactic brain biopsy in patients with leukemia presenting central ...

New potential for Alzheimer disease biomarker testing found in dried blood collection derived from capillary blood.

Blood biomarkers like p-tau217 are emerging as a way to detect Alzheimer's disease. The first FDA-approved blood-based ...

A technology that diagnoses various diseases, including Alzheimer’s and Parkinson’s, using just a few drops of blood from a ...

BrainSpace, a medical technology company building automated solutions for neuro injury, illness and degeneration, today announced that the U.S. Food and Drug Administration (FDA) has granted 510(k) ...

Objective: To analyze the clinical characteristics and cerebrospinal fluid (CSF) biochemical indexes, tumor markers (TM) and cytomorphological indexes of patients with meningeal carcinomatosis (MC), ...

Awa Kane *, Maryam Aida Kane, Aminata Mbaye, Guilaye Diagne, Ndeye Fatou Sow, Eva Sophie Sène, Amadou Sow, Yaye Joor Dieng, Djenaba Fafa Cissé, Marie Paula Absa Dione, Mame Awa Ndao, Ndeye Astou Diop, ...

Background A growing arsenal of treatment options for relapsing multiple sclerosis (RMS) emphasises the need for early prognostic biomarkers. While evidence for individual markers exists, ...

Parkinsonian disorders are difficult to diagnose. Clinical symptoms often overlap with criteria for other diseases, and clinicians can only make a definitive diagnosis postmortem. Now, a study ...